Lyfegen Unveils Generative AI to Transform Drug Contracting and Accelerate Patient Access
New AI capability enables structured, scalable contracting decisions amid accelerating global pricing complexity BASEL, Switzerland, March 3, 2026 /PRNewswire/ — Lyfegen, a global provider of innovative drug access, contracting and rebate management solutions,
